INS and type 2 diabetes mellitus: Nonetheless, our findings show that type 2 diabetes mellitus patients are characterised by increased plasma levels of LIGHT, and our in vitro findings suggest that LIGHT could contribute to the progression of this disorder by attenuating insulin secretion in pancreatic islet cells and by contributing to vascular inflammation.